May Orfali, MD

May Orfali, MD has a diverse work experience in the medical field. May currently serves as the Chief Medical Officer at Harbinger Health since May 2023. Prior to this, they worked at Bioasis Technologies Inc. as a Medical Advisor and CMO Consultant from November 2021 to the present. May also founded and served as the Owner and Principal Consultant at Rare Disease and Oncology Consulting, LLC starting from December 2018. Additionally, they have held various roles at Sigilon Therapeutics, Inc., including EVP and CMO, Interim CMO, and CMO Consultant, from October 2021 to April 2023. May has also served as a Board Member at Balanced Biotech Inc. since May 2020. Before that, they worked as a Medical and Clinical Development Consultant at SSI Strategy from January 2020 to November 2021. May was a CMO consultant at PYC Therapeutics from June 2020 to October 2020, and at Orphan Technologies from July 2019 to February 2020. May held the position of Chief Medical Officer at CANbridge Life Sciences Ltd. from July 2018 to December 2018. Prior to these roles, they had an extensive tenure at Pfizer, where they held positions such as Executive Director, Global Product Development- Rare Disease, Rare Disease Lead, Global Innovative Pharma BU, Global Medical Asset Lead- Hematology, and Senior Director, Medical Oncology- Clinical R&D, from 2009 to 2018.

May Orfali, MD completed their education in a chronological order. May first attended Baghdad Medical School in Iraq, where they obtained their Doctor of Medicine (MD) MBCHB Diploma in 1991. Their field of study at this time was Internal Medicine & General Surgery.

Following that, they pursued further education at Harvard University, where they completed a Pediatric Hematology-Oncology Fellowship Program. This program spanned from an unspecified start year to 1998.

Lastly, May Orfali, MD earned their Master of Business Administration (MBA) from the University of Cambridge. Their focus of study during this period was Pharmaceutical Sciences, and they completed their degree in 2013.